# A Study of the Efficacy and Safety of Topiramate in the Prevention of Migraine

> **NCT00231595** · PHASE3 · COMPLETED · sponsor: **Johnson & Johnson Pharmaceutical Research & Development, L.L.C.** · enrollment: 768 (actual)

## Conditions studied

- Migraine
- Common Migraine
- Classic Migraine
- Headache

## Interventions

- **DRUG:** topiramate

## Key facts

- **NCT ID:** NCT00231595
- **Lead sponsor:** Johnson & Johnson Pharmaceutical Research & Development, L.L.C.
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2001-03
- **Primary completion:** —
- **Final completion:** 2002-11
- **Target enrollment:** 768 (ACTUAL)
- **Last updated:** 2010-11-19


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00231595

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00231595, "A Study of the Efficacy and Safety of Topiramate in the Prevention of Migraine". Retrieved via AI Analytics 2026-06-25 from https://api.ai-analytics.org/clinical/NCT00231595. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*